ÀÌ ÆäÀÌÁö´Â 'infor.cgi' ÆÄÀÏ¿¡ ÀÇÇؼ Ãâ·ÂµÇ¾ú½À´Ï´Ù. Å×Å©³ëÆ®¿î¿µ¿¡ ¹Ýµå½Ã ÇÊ¿äÇÑ ÆÄÀÏÀº ¾Æ´Ï´Ï ÇÊ¿äÇÒ °æ¿ì¿¡¸¸ ¿ëµµ¿¡ ¸Â°Ô ÆíÁýÇØ »ç¿ëÇϽʽÿÀ, °¢ º¸µåº° [Àüü/¿À´Ã] ±Ûµî·Ï¼ö¸¦ Ç¥½ÃÇØ ÁÖ°í , ÀüüÅëÇÕ°Ë»ö , ¸Þ¸ðÀå µîÀ» Ãâ·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ±¸Ã¼Àû ¼³¸íÀº infor.cgi ¼Ò½º³»¿¡ ÀÖ½À´Ï´Ù. |
¡á BOARD INDEX - °¢ º¸µå¿¡ ´ëÇÑ [Àüü/¿À´Ã] ±Û µî·Ï¼ö°¡ ÀÚµ¿ Ç¥½ÃÇϱâ | ||
ÀÚÀ¯°Ô½ÃÆÇ [12] | Áú¹®´äº¯ | ÆË´Ï´Ù |
ÅõÇ¥, Åä·Ð¹æ [0] | °ø°³ÀÚ·á½Ç | »ð´Ï´Ù |
¾ÆÀÌÄÜ ¹ðÅ© | ȸ¿øÀü¿ë ¹æ | ÀÚÀ¯È«º¸ |
¸Þ½ÃÁö | ¹æ¸í·Ï | °ü¸®ÀÚ ¸Þ¸ð |
¡á ¸Þ¸ðÀå È°¿ëÇϱâ | |||
beneficial in a randomized, prospective | 51 | ||
products before beginning more extensive | 50 | ||
Ile that effectively destabilizes the ce | 49 | ||
the Centers for Disease Control and Prev | 48 | ||
prior to sexual intercourse. Several typ | 47 | ||
Common side effects include headache, di | 46 | ||
was originally developed in France by n | 45 | ||
following details may be pertinent: The | 44 | ||
CUV), for the treatment of solar urticar | 43 | ||
which has penetrated the epithelial-conn | 42 | ||
calmodulin kinase II (CaMKII) inhibitor, | 41 | ||
Caustic chemicals may cause ulceration o | 40 | ||
own Table of drugs for leading online e | 39 | ||
be modified or manufactured to avoid the | 38 | ||
suggestive of heightened gamma band acti | 37 | ||
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] |